Medicine and Dentistry
Adverse Event
20%
Aflibercept
100%
Age Related Macular Degeneration
100%
Bevacizumab
40%
Optical Coherence Tomography
100%
Ranibizumab
40%
Retinal Detachment
40%
Spectral Domain Optical Coherence Tomography
20%
Subretinal Fluid
40%
Vasculotropin
20%
Visual Acuity
40%
Nursing and Health Professions
Adverse Event
20%
Aflibercept
100%
Age Related Macular Degeneration
100%
Bevacizumab
40%
Optical Coherence Tomography
100%
Ranibizumab
40%
Retina Detachment
40%
Spectral Domain Optical Coherence Tomography
20%
Subretinal Fluid
40%
Vasculotropin
20%
Visual Acuity
40%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
20%
Aflibercept
100%
Age Related Macular Degeneration
100%
Bevacizumab
40%
Ranibizumab
40%
Retina Detachment
40%
Subretinal Fluid
40%
Vasculotropin
20%
Neuroscience
Adverse Effect
20%
Aflibercept
100%
Age-Related Macular Degeneration
100%
Bevacizumab
40%
Ranibizumab
40%
Vascular Endothelial Growth Factor
20%
Keyphrases
Eylea
25%
OCT Segmentation
100%
Total pigments
25%
Immunology and Microbiology